Clinical implications of fetuin-A

Affiliations

¹ Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria.
² Department of Internal Medicine I, Divisions of Nephrology and Endocrinology, Paracelsus Medical University, Salzburg, Austria.
³ Department of Internal Medicine I, Division of Cardiology, Friedrich Schiller University Jena, Jena, Germany.
⁴ Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria. Electronic address: michael.lichtenauer@chello.at.

Review

Peter Jirak et al. Adv Clin Chem. 2019.

. 2019:89:79-130.

doi: 10.1016/bs.acc.2018.12.003. Epub 2019 Feb 8.

¹ Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria.
² Department of Internal Medicine I, Divisions of Nephrology and Endocrinology, Paracelsus Medical University, Salzburg, Austria.
³ Department of Internal Medicine I, Division of Cardiology, Friedrich Schiller University Jena, Jena, Germany.
⁴ Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University, Salzburg, Austria. Electronic address: michael.lichtenauer@chello.at.

Abstract

Fetuin-A, also termed alpha2-Heremans-Schmid glycoprotein, is a 46kDa hepatocyte derived protein (hepatokine) and serves multifaceted functions.

Keywords: Atherosclerosis; Calcification; Cardiovascular disease; Chronic kidney disease; Fetuin-A.